Stay updated on Upadacitinib vs Placebo in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a 'Rheumatoid arthritis' tag and a Related topics section linking to MedlinePlus Genetics to aid navigation.SummaryDifference0.1%

- Check17 days agoChange DetectedLocations section reorganized into a single 'Locations' list (Aichi-ken, Fukuoka, Gunma, Hokkaido, Hyōgo, Kanagawa, Kawachinagano-shi, Kumamoto, Miyagi, Miyazaki, Niigata, Saitama, Tochigi, Tokyo, Yamaguchi) and includes a 'Revision: v3.3.3' tag. The previous 'X Locations' subsections were removed.SummaryDifference1%

- Check24 days agoChange DetectedThe Rheumatoid arthritis topic and the related MedlinePlus Genetics section have been removed from the page. This reduces visible disease-context on the study details page and may affect how users access disease-specific information.SummaryDifference0.1%

- Check39 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing v3.3.1. This appears to be a minor system update with no changes to the study content or functionality.SummaryDifference0.0%

- Check46 days agoChange DetectedPubMed publications note updated to indicate automatic filling from PubMed and that articles may not be about the study, and the revision label changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check53 days agoChange DetectedRheumatoid arthritis and related topics: MedlinePlus Genetics were added to the page, and a generic government funding notice about operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Upadacitinib vs Placebo in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.